Miniaturized high-throughput screening offers great promise for increasing the productivity of the pharmaceutical drug discovery process. By monitoring interactions of single molecules in femtoliter volumes, fluorescence correlation spectroscopy (FCS) offers the highest potential as the detection technique in the nanoscale. The authors () summarize the current status of practical experiences with FCS assays for HTS and explore the scope for further developments. Copyright (C) 1998 Elsevier Science Ltd.
|Number of pages||9|
|Journal||International Journal of Immunopharmacology|
|Publication status||Published - 1 Jan 1999|